The Global Medical Probiotics Market Growth Accelerated By Rising Health Awareness
Medical probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. They help maintain the balance of intestinal flora and strengthen the immune system. The growing knowledge about gut health and its link to overall well-being has boosted demand for probiotic supplements and food & beverage products.
The global Medical Probiotics
Market is estimated to be valued at US$ 69.5 billion in 2023 and is expected to
exhibit a CAGR of 19% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market key trends
Rising health awareness has been a key driver of growth in the medical probiotics market. Customers are increasingly recognizing the importance of probiotic dietary supplements in maintaining gut and digestive health. Probiotics are known to facilitate nutrient absorption and support immunity. Growing preference for natural and herbal remedies over synthetic drugs has further augmented demand. Research also indicates certain probiotic strains may aid in relieving conditions like irritable bowel syndrome. This has motivated food and supplement manufacturers to innovate new probiotic formulations targeted at specific health issues. Companies are also focusing on communication and education around benefits of probiotics to capture the opportunities in the rising industry.
Segment Analysis
The global medical probiotics market is segmented into bacteria type,
application, end user, and region. Based on bacteria type, the market is
categorized into Lactobacillus, Bifidobacterium, Streptococcus, and others. The
Lactobacillus segment dominates the market as these bacteria are commonly found
colonizing the gut of humans and help promote the growth of other helpful
bacteria. By application, the market is divided into nutritional supplements,
specialty nutrients, infant formula, and others. The specialty nutrients
segment holds the largest market share as probiotics are increasingly being
included in dietary supplements and foods designed to support specific health
conditions. Based on end users, the market is classified into hospitals,
clinics, probiotic dietary supplements, and others.
Key Takeaways
The global Medical
Probiotics market Share is expected to witness high growth. The global
Medical Probiotics Market is estimated to be valued at US$ 69.5 billion in 2023
and is expected to exhibit a CAGR of 19%
over the forecast period 2023 to
2030.
North America currently
dominates the market owing to the growing prevalence of lifestyle diseases,
established healthcare infrastructure, and high awareness about probiotics
health benefits in the region.
Key players operating in the
medical probiotics market are BioGaia AB, Probi AB, i-Health, Winclove
Probiotics, UAS Laboratories, Nestle S.A. Probiotics play a vital role in
maintaining gut health and immunity. They help improve digestion, treat
intestinal disorders like IBS, and reduce risk of illnesses. Their increased
usage during the Covid-19 pandemic has positively impacted industry growth.
Companies are investing in R&D to develop innovative strains, improve shelf
life, and expand applications based on clinical evidence.
Explore more related article on this topic: https://www.ukwebwire.com/health-benefits-is-driving-the-medical-probiotics-market/
https://blogger-veritas.blogspot.com/2024/01/water-treatment-chemicals-market-growth.html
Comments
Post a Comment